Yangzhou University Medical Academy, Yangzhou, Jiangsu, China.
The Second Clinical College of Dalian Medical University, Dalian, Liaoning, China.
Cancer Med. 2019 Dec;8(18):7890-7902. doi: 10.1002/cam4.2662. Epub 2019 Oct 30.
There is limited information from population-based cancer registries regarding prognostic features of bilateral primary breast cancer (BPBC).
Female patients diagnosed with BPBC between 2004 and 2014 were randomly divided into training (n = 7740) and validation (n = 2579) cohorts from the Surveillance, Epidemiology, and End Results Database. We proposed five various models. Multivariate Cox hazard regression and competing risk analysis were to explore prognosis factors in training cohort. Competing risk nomograms were constructed to combine significant prognostic factors to predict the 3-year and the 5-year survival of patients with BPBC. At last, in the validation cohort, the new score performance was evaluated with respect to the area under curve, concordance index, net reclassification index and calibration curve.
We found out that age, interval time, lymph nodes invasion, tumor size, tumor grade and estrogen receptor status were independent prognostic factors in both multivariate Cox hazard regression analysis and competing risk analysis. Concordance index in the model of the worse characteristics was 0.816 (95% CI: 0.791-0.840), of the bilateral tumors was 0.819 (95% CI: 0.793-0.844), of the worse tumor was 0.807 (0.782-0.832), of the first tumor was 0.744 (0.728-0.763) and of the second tumor was 0.778 (0.762-0.794). Net reclassification index of the 3-year and the 5-year between them was 2.7% and -1.0%. The calibration curves showed high concordance between the nomogram prediction and actual observation.
The prognosis of BPBC depended on bilateral tumors. The competing risk nomogram of the model of the worse characteristics may help clinicians predict survival simply and effectively. Metachronous bilateral breast cancer presented poorer survival than synchronous bilateral breast cancer.
基于人群的癌症登记处关于双侧原发性乳腺癌(BPBC)预后特征的信息有限。
从监测、流行病学和最终结果数据库中随机抽取 2004 年至 2014 年间诊断为 BPBC 的女性患者,分为训练(n=7740)和验证(n=2579)队列。我们提出了五种不同的模型。多变量 Cox 风险回归和竞争风险分析用于探索训练队列中的预后因素。构建竞争风险列线图,将显著的预后因素结合起来,预测 BPBC 患者的 3 年和 5 年生存率。最后,在验证队列中,通过曲线下面积、一致性指数、净重新分类指数和校准曲线来评估新评分的性能。
我们发现,年龄、间隔时间、淋巴结侵犯、肿瘤大小、肿瘤分级和雌激素受体状态在多变量 Cox 风险回归分析和竞争风险分析中都是独立的预后因素。模型中较差特征的一致性指数为 0.816(95%CI:0.791-0.840),双侧肿瘤为 0.819(95%CI:0.793-0.844),较差肿瘤为 0.807(0.782-0.832),第一个肿瘤为 0.744(0.728-0.763),第二个肿瘤为 0.778(0.762-0.794)。3 年和 5 年的净重新分类指数分别为 2.7%和-1.0%。校准曲线显示,列线图预测与实际观察之间具有高度一致性。
BPBC 的预后取决于双侧肿瘤。较差特征模型的竞争风险列线图可以帮助临床医生简单有效地预测生存情况。异时性双侧乳腺癌的生存率较同时性双侧乳腺癌差。